Abstract
Blood pressure lowering per se provides a large proportion of the benefit associated with antihypertensive treatment. Blood pressure should be reduced to
| Original language | English |
|---|---|
| Pages (from-to) | 85-90 |
| Number of pages | 6 |
| Journal | High Blood Pressure and Cardiovascular Prevention |
| Volume | 15 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2008 |
Fingerprint
Keywords
- Calcium antagonist
- Clinical trials
- Guidelines
- Hypertension
- Organ damage
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Dihydropiridinic calcium-channel antagonists in the 2007 ESH/ESC hypertension guidelines. / Mancia, Giuseppe.
In: High Blood Pressure and Cardiovascular Prevention, Vol. 15, No. 2, 2008, p. 85-90.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Dihydropiridinic calcium-channel antagonists in the 2007 ESH/ESC hypertension guidelines
AU - Mancia, Giuseppe
PY - 2008
Y1 - 2008
N2 - Blood pressure lowering per se provides a large proportion of the benefit associated with antihypertensive treatment. Blood pressure should be reduced to
AB - Blood pressure lowering per se provides a large proportion of the benefit associated with antihypertensive treatment. Blood pressure should be reduced to
KW - Calcium antagonist
KW - Clinical trials
KW - Guidelines
KW - Hypertension
KW - Organ damage
UR - http://www.scopus.com/inward/record.url?scp=48349136988&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=48349136988&partnerID=8YFLogxK
U2 - 10.2165/00151642-200815020-00007
DO - 10.2165/00151642-200815020-00007
M3 - Article
VL - 15
SP - 85
EP - 90
JO - High Blood Pressure and Cardiovascular Prevention
JF - High Blood Pressure and Cardiovascular Prevention
SN - 1120-9879
IS - 2
ER -